Description: The purpose of this paper is to study mortality-based securities, such as mortality bonds and swaps, and to price the proposed mortality securities. The focus is on individual annuity data, although some of the modeling techniques could be applied to other lines of annuity or life insurance.

Description: This paper suggests a possible framework for the mandatory annuitization of U.S. retirement savings, considers the experience of other countries and analyzes the advantages and disadvantages of mandatory annuitization.

Description: This paper explains how legal reforms related to annuities have decreased the popularity of annuities among plan sponsors, and then describes how a proposal for a federal charter option for life insurance companies could hold some promise for persuading plan sponsors to put annuities back into savings plans.

Description: This paper examines the risk associated with long-term care, as well as a variety of insurance-based vehicles that can assist consumers in protecting them from this risk.

Description: This is a research project on possible replacement indices for the 30 year treasury rates used to value current liability for defined benefit pension plans in the US.

Description: Disease management [DM] is a health care intervention targeted to individuals with chronic diseases chronics. To justify the investment by payers in DM, it is important to demonstrate beneficial clinical and financial outcomes. This paper analyzes the health cost trends between the chronic and non-chronic populations. Paper 7 of an 8 paper series on 'An Introduction to Care Management Interventions and Their Implications for Actuaries'.

Description: Examines historical life insurance and annuity policyholder mortality improvement trends and/or mortality improvement rates and how they compare to that of the general US and international populations. Discusses techniques for modeling and projecting future mortality improvements

Description: Responds to questions received during the webcast with regards to modeling long term medical trends for valuation purposes. Questions cover testing the model against publicly traded companies, the calculation of growth rate in the model, the income multiplier as the population ages, model relevance to Canada, factoring in of extra disease burdens, exclusion of aging in the model, and the effect of the globalization of health care.

Description: A discussion of areas of AAT where the Actuary uses a considerable degree of discretion and judgment and guidance is limited.

Description: Mortality Credibility and its use within VM-20.